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Background: Peritoneal dialysis-associated peritonitis (PD-peritonitis) due to Mycobacterium spp is uncommon.
Non-tuberculous Mycobacterium (NTB) PD-peritonitis can present in a similar fashion to more common causes of
bacterial PD-peritonitis. We describe the first reported case of multiresistant Mycobacterium fortuitum PD-peritonitis
in an Australian patient.
Case presentation: A 38 year-old woman developed mild PD-peritonitis during an overseas holiday. Treatment
was complicated by delayed diagnosis, requirement for special investigations, treatment with multiple antibiotics,
and conversion to haemodialysis following removal of her Tenckhoff catheter.
Conclusion: This case demonstrates the diagnostic yield of pursuing further investigations in cases of initially
culture-negative, problematic PD-peritonitis. A systematic review of the literature identified only 17 reports of
M. fortuitum PD-peritonitis. Similar to our case, a delay in microbiological diagnosis was frequently noted and the
Tenckhoff catheter was commonly removed at the time of diagnosis. The type and duration of antibiotic therapy
also varied widely so the optimum treatment appears to be poorly defined.
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Peritoneal dialysis-associated peritonitis (PD-peritonitis)
due to Mycobacterium spp is uncommon, particularly in
patients receiving treatment in developed countries. Non-
tuberculous Mycobacterium (NTB) PD-peritonitis can
present in a similar fashion to more common causes of
bacterial PD-peritonitis. However, treatment is often com-
plicated by apparent culture negative dialysate effluent,
prolonged treatment courses requiring multiple antibiotics
and Tenckhoff catheter removal requiring a change to
haemodialysis. We describe the first case of M. fortuitum
PD-peritonitis in an Australian patient, requiring Tenckh-
off catheter removal and permanent conversion to
haemodialysis. The literature is reviewed regarding the
presentation and treatment of this condition.* Correspondence: 1darren1@gmail.com
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A 38 year-old woman with end-stage renal disease due
to Factor-H deficient haemolytic uraemic syndrome had
been treated with peritoneal dialysis for 6 months with-
out complication. The patient practiced continuous am-
bulatory peritoneal dialysis with four exchanges per day
of two litres of 2.5% dextrose, each of 4 hour duration.
The patient had no prior comorbidities nor history of
significant infections. She embarked on a cruise ship
holiday in the Pacific. Three days after arriving in North
America, she developed nausea which progressed over
one week to include mild abdominal pain and diarrhoea.
Although her dialysate effluent was cloudy, the mildness
of her symptoms prompted the patient to continue the
final two weeks of her holiday without any antibacterial
treatment. She had no exit site symptoms at any point
and reported adherence to her aseptic technique train-
ing. Upon return to Australia she promptly presented to
hospital.
On presentation to hospital she was febrile (38°C) and
tachycardic (108 beats/minute) with a blood pressure oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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distension and right iliac fossa tenderness. Bowel sounds
were present and the Tenckhoff catheter exit site was
unremarkable. The peritoneal fluid was turbid with
>100 x106/mL leukocytes, predominantly neutrophils.
The peritoneal dialysate cultures were initially
reported as culture negative and the patient was treated
empirically with intraperitoneal vancomycin and genta-
micin. After an early clinical improvement she developed
a recurrence of fever and abdominal pain four days after
admission. An abdominal computerised tomography
scan demonstrated multiple loculations with thin high
attenuation rims (Figure 1.). Concurrently, the initial di-
alysate effluent samples grew gram-positive bacilli after
four days consistent with a rapidly-growing non-
tuberculous mycobacterium. Gene sequencing by poly-
merase chain reaction of the isolate identified it to be
M. fortuitum. Subsequent antibiotic susceptibility testing
demonstrated sensitivity to amikacin and ciprofloxacin,
intermediate resistance to cefoxitin, and resistance to
clarithromycin, doxycycline, imipenem and trimetho-
prim/sulfamethoxazole.
The patient underwent surgical removal of the
Tenckhoff catheter, disruption of loculations and lavage
of the peritoneal space. Her subsequent antibiotic regi-
men of oral moxifloxacin, clarithromycin and doxycyc-
line was complicated by the development of intolerable
nausea. She was then established on oral moxifloxacin
and linezolid for six months with a sustained clinical re-
sponse. Treatment duration was empirically determined.
After completion of her course of antibiotics re-Figure 1 Computerised tomography of the abdomen,
demonstrating multiple loculations with thin high attenuation
rims.insertion of the Tenckhoff catheter was attempted but
abandoned after multiple intraperitoneal adhesions were
found.
Literature review
We conducted a systematic review of the literature of
M. fortuitum PD-peritonitis. 17 reports were identified
occurring in 12 males and 5 females aged between 15
and 83 years (Table 1.). The geographic spread included
reports from North America (8 patients), Asia (4
patients), Europe (3 patients) and the Middle East (2
patients) with none from Australia.
The duration of symptoms prior to hospital presentation
was incompletely reported and a delay in microbiological
diagnosis was commonplace (median 7 days, interquartile
range 4-8 days). Intra-abdominal loculations and collec-
tions occurred in 2 previous reports. The Tenckhoff cath-
eter was removed in all but two reported cases and mostly
at the time of diagnosis. The duration of antibiotic therapy
varied widely (between 1 and 12 months), so the optimum
treatment appears to be poorly defined. In our patient the
6 month duration was chosen based on typically reported
dosing periods. Antibiotic sensitivity by disc diffusion was
reported in 10 of the 17 reports. M. fortuitum was almost
universally sensitive to amikacin, ciprofloxacin, imipenem
and clarithromycin. Resistance to cephalosporins, tetracy-
clines and other macrolides was variable. Similarly, there
was marked variability in the antibiotic regimens utilised
and the rationale for these choices were incompletely
described. The more common antibiotics utilised included
amikacin in 7 reports, ciprofloxacin in 4 reports and doxy-
cycline in 3 reports with combination therapy common.
Only one death was reported in a patient with M. fortui-
tum PD-peritonitis (Table 1).
Conclusion
We describe the first case of M. fortuitum PD-peritonitis
and the third case of any NTM PD-peritonitis in an
Australian patient [15,16]. The place and mode of infec-
tion remain unclear. Our patient had recently returned
from a one month overseas holiday traversing the Paci-
fic, the Caribbean and North America. Given the slow
growth rate of M. fortuitum her peritoneum may have
been inoculated either before leaving Australia, whilst
travelling through the Caribbean or North America. The
slow growth rate of M. fortuitum presumably accounts
for the mild and indolent development of symptoms and
may be a clinical characteristic of NTM PD-peritonitis.
The subacute course may predispose to the chronic se-
quelae of infection. Our case brings the number of cases
with reported intra-abdominal loculations to three in
eighteen. This proportion could well be an underesti-
mate with only a minority of reported patients having
imaging or persisting with peritoneal dialysis.
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Table 1 Published reports of M fortuitum PD-peritonitis (Continued)
Tokyo, Japan [13] 50 y/o male 3 weeks Not reported Amikacin, sulbactam (c,d) Yes
Singapore,
Singapore b [14]





No Patient died at
2 months from
malignancy
aThis publication also reported on a suspected case of PD-peritonitis and two confirmed cases of Tenckhoff catheter exit site infections due to M. fortuitum.
bThis publication also listed a second (male) patient with M. fortuitum PD-peritonitis in a table, but described the patient to be a female with M. abscessus PD-
peritonitis in the text. Due to inconsistency in the report, this case was excluded.
cDuration of therapy not known.
dRoute of administration not known.
IP intraperitoneal, PO per oral, IV intravenous.
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spp. in Australia has not been described. On the basis of
registry data, it is anticipated to be low given the rela-
tively high cure rates of all cases of PD-peritonitis in
Australia after a median duration of treatment of 13 days
with primarily vancomycin or cephalosporins with/with-
out gentamicin [17]. There is considerable variability in
the proportion of cases of PD-peritonitis that are
culture-negative in Australian and New Zealand renal
units which may reflect differences in disease prevalence
and/or diagnostic and management practices [17].
Guidelines of the International Society of Peritoneal
Dialysis (ISPD) recommend that a negative dialysate cul-
ture at 3 days in the presence of ongoing clinical evidence
of peritonitis calls for specialized cultures for atypical
causes of peritonitis [18]. If there is a clinical suspicion of
infection with Mycobacterium spp., repeated smears and
centrifuge of effluent sediment with a combination of
solid- and fluid-medium culture are suggested.
The safety and timing for attempted re-insertion of
Tenckhoff catheters after treatment, and technique sur-
vival, is incompletely reported. The ISPD guidelines rec-
ommend consideration of catheter removal following a
diagnosis of Mycobacterial peritonitis although data sup-
porting this recommendation are limited.
Non-tuberculous Mycobacteria are a rare but serious
cause of PD-peritonitis with high rates of Tenckhoff
removal and conversion to haemodialysis. This is the
first report of M. fortuitum PD-peritonitis reported in
Australia and the diagnosis was prompted by inadequate
response to empiric antibiotics and confirmed by special
investigations that are uncommonly utilised in most
cases of PD-peritonitis.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
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